The growth of this market is majorly driven by the launch of new products and favorable reimbursement scenario. However, the shift toward minimally invasive surgeries and adverse effect of hemostats are the major factors restraining the growth of this market.
The report "European Hemostats & Sealants Market by Brand (Hemopatch [Baxter], Tachosil [Takeda], Veriset [Medtronic], Avitene [C.R Bard], Sangustop [B Braun], Lyostypt [B Braun]), Country (Germany, Uk, France, Italy & Spain) - Forecast to 2027", The hemostats and sealants (focused products) market is projected to reach USD 109 million by 2027 from USD 63 million in 2019, at a CAGR of 7.0%.
The study involved four major activities to estimate the current size of the hemostats and sealants (focused brands) market. Exhaustive secondary research was conducted to collect information on the market and its different subsegments.
The next step was to validate these findings, assumptions, and sizing estimates with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of segments and subsegments.
Based on focused products, Tachosil is projected to register the highest growth during the forecast period
Based on focused products, the market is segmented into Tachosil, Lyostypt, Sangustop, Veriset, Avitene, and Hemopatch. Tachosil is expected to grow at the highest CAGR during the forecast period, mainly due to the increasing demand for this product among end users.
Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=115823197
Key questions addressed in the report:
# What are the growth opportunities in the hemostats and sealants market across major countries in Europe in the future?
# What are the key drivers and restraints in the hemostats and sealants market?
# What are the key brands in the hemostats and sealants market?
# Which are the key countries in the hemostats and sealants market?
# What are the most preferred brands amongst end users?
Hemostats help in controlling bleeding at the site of wound or performing various open surgeries. The different types of products used include thrombin-based hemostats, combination hemostats, oxidized regenerated cellulose-based hemostats, gelatin-based hemostats, and collagen-based hemostats. Of these, combination hemostats are anticipated to grow at the highest rate in Europe, as they reduce the risk of side-effects post-application
Germany commands the largest share of the market
Based on region, the hemostats and sealants (focused products) market is segmented into Germany, the UK, France, Italy, and Spain. Germany dominates the hemostats and sealants market due to its large patient population and the favorable reimbursement scenario for the usage of hemostats.
Report Objectives:
# To define, describe, and forecast the European hemostats and sealants market (by value) on the basis of focused brand and country
# To identify micromarkets and the drivers, restraints, industry-specific challenges, opportunities, and trends affecting the growth of the focused brands market.
# To profile focused brands and comprehensively analyze their market shares in focused European countries.
Key players operating in the hemostats and sealants (focused products) market include B. Braun (Germany), Medtronic (Ireland), C. R. Bard (US), Takeda (Japan), and Baxter (US).
Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=115823197
The market for hemostats and sealants is anticipated to grow mainly due to the launch of the new products, M&A’s, and favorable reimbursement scenario in Europe. However, the increasing preference for minimally invasive surgeries and the reducing preference for the usage of hemostats while performing surgeries are expected to hinder the growth of this market during the forecast year. Leading players operating in this market are Ethicon (J&J), Baxter, Pfizer, Baxter, C. R. Bard, and B. Braun.
According to the new market research report “Non-Invasive Prenatal Testing Market by Instruments (Ultrasound, NGS, PCR, Microarray), Consumables, Method (FCMB, cf-DNA), Application (Trisomy, Microdeletion, Genetics, Rh factor) & End User (Hospital, Diagnostic Labs) - Global Forecast to 2021", published by MarketsandMarkets™, analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia, and the Rest of the World (RoW).Browse and in-depth TOC on “Non Invasive Prenatal Testing Market”110 - Tables48 - Figures150 - PagesFor Bundle Reports @ https://www.marketsandmarkets.com/RequestBundleReport.asp?id=145607690The global NIPT market is expected to reach USD 2.88 Billion by 2021 from USD 1.35 Billion in 2016, at a CAGR of 16.4% during the forecast period.The major factors driving the growth of this market include the growing preference for non-invasive techniques over invasive methods, rising focus on reimbursement for NIPT, launch of new and advanced NIPT products, and increasing maternal age (associated with growth in the risk of chromosomal abnormalities in babies).
Furthermore, untapped emerging markets are expected to offer potential growth opportunities to players operating in the NIPT market during the forecast period.To Get 10% Customization on Report @ https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=145607690On the basis of product, the market is classified into consumables and instruments.
The consumable segment is further divided into assay kits & reagents and disposables.
The instruments segment is divided into ultrasound devices, NGS systems, PCR instruments, microarrays, and other instruments.
In 2016, the consumables segment accounted for the largest share of the market.
The high growth in this segment is attributed to the repeated requirements of consumables as compared to instruments in NIPT.To speak to our analyst for a discussion on the above findings, click Speak to Analyst@https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=145607690The market is highly fragmented with several big and emerging players.
According to the new market research report the Spinal Implants Devices Market is projected to reach USD 13.8 billion by 2025 from USD 10.3 billion in 2019, at a CAGR of 5.0%.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=712This market is primarily driven by the launch of advanced bone grafting products, the advancements in spine surgery technologies, increasing incidence of spinal disorders and the increasing adoption of minimally invasive spine surgeries.Based on product, the market is segmented into thoracic fusion and lumbar fusion devices, cervical fusion devices, spine biologics, non-fusion devices, vertebral compression fracture treatment devices, spinal decompression devices, and spine bone stimulators.
The thoracic fusion and lumbar fusion devices segment accounted for the largest share of the market in 2019.
The large share of this segment can be attributed to the increasing incidence of lumbar degenerative disc disease and the growing number of product launches.Based on the type of surgery, the market is segmented into open and minimally invasive surgeries.
The open surgeries segment accounted for the largest share of the Spinal Surgery Devices Market in 2019.
The large share of this segment can be attributed to the increasing preference for open spine surgeries among medical professionals, rising incidence of spinal deformities, and technological advancements in spinal fusion surgeries.
In addition, some spine procedures, such as spinal implant insertions, can only be done through open surgeries, which is another major factor supporting market growth.On the basis of technology, the Spinal Surgery Devices Market is segmented into spinal fusion and fixation, vertebral compression fracture treatment, motion preservation/non-fusion, and spinal decompression technologies.
The growing prevalence of dental disorders, rising geriatric population, and the growing dental tourism in emerging countries are the major factors driving the growth of this market.
On the other hand, the presence of stringent regulatory and clinical processes is one of the major factors restraining market growth.The global dental biomaterials market is projected to reach USD 9.6 billion by 2023 from USD 6.7 billion in 2018, at a CAGR of 7.4%.
Market Dynamics+ Drivers+ Increasing Penetration of Dental Implants+ Increasing Prevalence of Dental Disorders+ Rising Geriatric Population+ Growing Dental Tourism in Developing Countries+ Increasing Disposable Income in Developing CountriesRequest for Free Sample Pages - https://www.marketsandmarkets.com/requestsampleNew.asp?id=198160556The market is segmented into metallic, metal-ceramic, ceramic, polymeric, and natural dental biomaterials the metallic biomaterials segment accounted for the largest share in 2018.
The large share of this segment can be attributed to the increasing penetration of Dental Implants and the wide applications of metallic biomaterials in dentistry.The market is categorized into implantology, prosthodontics, orthodontics, and other applications.
In 2018, the implantology application segment accounted for the largest share of the market.
The large share of this segment can be attributed to the increasing penetration of dental implants globally, high price and volume requirements of titanium used in manufacturing dental implants, rising incidence of dental diseases, increasing demand for cosmetic dentistry, growing dental tourism in emerging markets, and increasing disposable incomes in developing countries.View Complete Press Releases - https://www.marketsandmarkets.com/PressReleases/dental-biomaterial.asp
